FDA Regulations and New Legislation for Marketing Cosmetics in the U.S

Why Should You Attend:

The webinar will cover laws and regulations for successful marketing and compliance of cosmetics in the U.S. It will help clarify what claims and product labeling are appropriate for cosmetics to market them successfully and avoid problems with FDA compliance. Current FDA Warning letters will be discussed to understand FDA’s changing views on cosmetic enforcement. Adverse Event Reporting for Cosmetics will be discussed with focus on how this will change under the Personal Care Products Safety Act.

Learning Objectives:

• To learn FDA Labeling requirements for Cosmetics & Personal Care Products
• To understand cosmetic claims and compliance issues and how to avoid FDA issues
• Learn what “Cosmeceuticals” are and how they can be legally marketed
• Learn about 2015 Proposed Cosmetics legislation, the Personal Care Products Safety Act
• Gain understanding of Good Manufacturing Practice systems for Cosmetics & Coming GMP regulations
• Learn Adverse Event Labeling & Reporting requirements for cosmetics and how these will change under the Personal Care Products Safety Act

Areas Covered in the Webinar:

• Laws and Regulations Applicable to U.S. Cosmetics
• Cosmetic Labeling Requirements
• Adverse Event Reporting for Cosmetics
• Cosmetic Claims and Compliance Issues
• Current Cosmetic GMP Requirements
• 2015 Proposed Cosmetics Legislation: The Personal Care Products Safety Act

Who Will Benefit:

• Regulatory Affairs Managers and Associates
• QA Managers
• Cosmetic Marketing Managers
• Attorneys
• Anyone interested in learning about cosmetic regulations and new proposed legislation

Norma Skolnik
Regulatory Consultant, EAS Consulting Group and NS Consulting

Norma Skolnik has over 35 years of regulatory experience working with the pharmaceutical and dietary supplement industries. She served as director of regulatory affairs for the Americas for Cadbury Adams. Prior to that she was director of regulatory affairs for the Adams Division of Pfizer and associate director of regulatory affairs for the Warner-Lambert company. She also served as director of regulatory affairs for Lederle Consumer Healthcare and as associate director of marketed product support for Lederle Laboratories and associate director of regulatory affairs for Wyeth. She currently works as a regulatory consultant.

Follow us :